aportes a la gestión necesaria para la sustentabilidad de la SALUD PÚBLICA como figura esencial de los servicios sociales básicos para la sociedad humana, para la familia y para la persona como individuo que participa de la vida ciudadana.
viernes, 18 de diciembre de 2009
RFA-HS-10-009: Recovery Act 2009 Limited Competition OS ARRA: Comparative Effectiveness Research to Optimize Prevention and Healthcare Management for the Complex Patient (R21)
AHRQ Announces New Funding Opportunity
Applications are due January 20, 2010
Comparative Effectiveness Research to Optimize Prevention and Healthcare Management for the Complex Patient
The Agency for Healthcare Research and Quality (AHRQ) under the American Recovery & Reinvestment Act of 2009 ("Recovery Act" or "ARRA"), Public Law 111-5, invites Exploratory/Developmental grant (R21) applications from organizations that aim to understand the comparative value of different strategies in the prevention and management of chronic illness in persons with specific constellations of co-morbid conditions.
The objectives of this Funding Opportunity Announcement are to:
Support comparative effectiveness research to allow prioritization of evidence-based services (testing and treatment) for patients with multiple co-morbidities (including physical and mental conditions), and suggest appropriate adaptations (in timing and frequency) of recommended preventive and care management guidelines for these patients.
Provide evidence to clarify how co-existing chronic conditions modify the safety or comparative value of proven treatments for chronic diseases and recommended preventive interventions.
Provide evidence to refine chronic disease quality measures for complex and frail patients.
To achieve these objectives, expected research approaches include mathematical modeling, statistical modeling, or epidemiologic studies that may be based on data from population surveys, medical databases from electronic health records, and possibly insurance claims data.
AHRQ anticipates awarding 12-18 grants; the total amount expected to be awarded is $6,000,000. The project period duration and total cost budget limits vary by type of study proposed. This is a one-time-only solicitation, resubmissions are not permitted.
For more information, please go to: http://grants.nih.gov/grants/guide/rfa-files/RFA-HS-10-009.html
abrir aquí, o bien en el vínculo previo anterior:
RFA-HS-10-009: Recovery Act 2009 Limited Competition OS ARRA: Comparative Effectiveness Research to Optimize Prevention and Healthcare Management for the Complex Patient (R21)
No hay comentarios:
Publicar un comentario